Earnings History Data for NeuroBo Pharmaceuticals (NRBO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | NRBO | NeuroBo Pharmaceuticals | 21.00 | -0.55 | -0.82 | 0.00 | NeuroBo Pharmaceuticals GAAP EPS of -$0.55 beats by $0.18 [11/7/2024 11:21 AM] |
2.72 | -0.02 (-0.73%) |
2.74 | 0.0 (0.00%) |
2.08 - 6.75 | 10,268 | 30,000 | 426 | ||
| 09-05-2024 | PM | NRBO | NeuroBo Pharmaceuticals | 19.00 | -1.32 | -0.95 | 0.00 | NeuroBo Pharmaceuticals GAAP EPS of -$1.32 [5/9/2024 10:49 AM] |
4.00 | 0.07 (1.78%) |
3.90 | -0.03 (-0.76%) |
2.89 - 6.75 | 34,596 | 20,000 | 236 | ||
| 01-04-2022 | PM | 8:00 AM ET (Apr 1) |
NRBO | NeuroBo Pharmaceuticals | 25.00 | -0.17 | -0.15 | 0.00 | NeuroBo Pharmaceuticals GAAP EPS of -$0.66 [4/1/2022 9:26 AM] |
0.9042 | 0.0 (0.23%) |
0.90 | 0.0 (-0.23%) |
0.67 - 6.57 | 46,001 | 480,000 | 846 | |
| 17-05-2021 | AH | 4:50 PM ET (May 17) |
NRBO | Neurobo Pharmaceuticals, Inc. | 61.00 | -0.15 | -0.16 | 0.00 | NeuroBo Pharmaceuticals EPS beats by $0.01 [5/17/2021 5:08 PM] |
3.12 | 0.08 (2.63%) |
0.0 | 0.0 (0.00%) |
2.72 - 14.43 | 276,697 | 60,000 | 0 | |
| 15-04-2021 | AH | 4:30 PM ET (Apr 15) |
NRBO | Neurobo Pharmaceuticals, Inc. | 74.00 | -0.13 | -0.19 | 0.00 | 3.24 | -0.45 (-12.20%) |
3.69 | 0.0 (0.00%) |
3.21 - 16.85 | 101,496 | 110,000 | 569 | ||
| 13-11-2020 | AH | NRBO | Neurobo Pharmaceuticals, Inc. | 87.00 | -0.19 | -0.17 | 0.00 | NeuroBo Pharmaceuticals EPS misses by $0.02 [11/13/2020 4:42 PM] |
5.06 | -0.20 (-3.80%) |
5.26 | 0.0 (0.00%) |
4.82 - 30.00 | 15,200 | 18,503 | 100 | ||
|
|
||||||||||||||||||
| 20-05-2020 | AH | NRBO | NeuroBo Pharmaceuticals, Inc. | 234.75 | -0.30 | 0.00 | -6.75 | NeuroBo Pharmaceuticals EPS misses by $0.20 [5/20/2020 4:37 PM] |
13.32 | -0.25 (-1.84%) |
14.63 | 0.33 (2.31%) |
5.95 - 36.22 | 1,751 | 19,117 | 401 | ||
|
|
||||||||||||||||||